A retrospective claims analysis of combination therapy in the treatment of adult attention-deficit/hyperactivity disorder (ADHD)
Open Access
- 8 June 2009
- journal article
- Published by Springer Nature in BMC Health Services Research
- Vol. 9 (1) , 95
Abstract
Combination therapy in managing psychiatric disorders is not uncommon. While combination therapy has been documented for depression and schizophrenia, little is known about combination therapy practices in managing attention-deficit/hyperactivity disorder (ADHD). This study seeks to quantify the combination use of ADHD medications and to understand predictors of combination therapy.Keywords
This publication has 23 references indexed in Scilit:
- Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential ResponseAmerican Journal of Psychiatry, 2008
- Is clozapine—aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?Journal of Psychopharmacology, 2007
- Preliminary Evidence of Riluzole Efficacy in Antidepressant-Treated Patients with Residual Depressive SymptomsBiological Psychiatry, 2007
- The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorderJournal of Psychopharmacology, 2006
- Functional Impairments in Adults With Self-Reports of Diagnosed ADHDThe Journal of Clinical Psychiatry, 2006
- Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective studyInternational Clinical Psychopharmacology, 2005
- Patterns and Predictors of Attention-Deficit/Hyperactivity Disorder Persistence into Adulthood: Results from the National Comorbidity Survey ReplicationBiological Psychiatry, 2005
- Pharmacotherapy of adult ADHDJournal of Clinical Psychology, 2005
- Adults with ADHDAnnals of the New York Academy of Sciences, 2001
- Pharmacokinetics and Clinical Effectiveness of MethylphenidateClinical Pharmacokinetics, 1999